P3 Health Partners ROE 2020-2024 | PIII

Current and historical return on equity (ROE) values for P3 Health Partners (PIII) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
P3 Health Partners ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $-0.14B $0.08B -107.24%
2024-09-30 $-0.10B $0.12B -71.40%
2024-06-30 $-0.07B $0.17B -42.86%
2024-03-31 $-0.07B $0.15B -78.59%
2023-12-31 $-0.06B $0.14B -119.37%
2023-09-30 $-0.13B $0.19B -916.36%
2023-06-30 $-0.12B $-0.14B 901.82%
2023-03-31 $-0.27B $0.00B -564.21%
2022-12-31 $-0.27B $0.01B -236.84%
2022-09-30 $-0.25B $0.08B -135.91%
2022-06-30 $-0.27B $0.11B -167.92%
2022-03-31 $-0.14B $0.26B -106.77%
2021-12-31 $-0.16B $0.27B -231.97%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.063B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.476B 53.14
Tempus AI (TEM) United States $9.826B 0.00
Hims & Hers Health (HIMS) United States $9.069B 145.79
Inspire Medical Systems (INSP) United States $4.756B 92.38
IRhythm Technologies (IRTC) United States $4.186B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $2.016B 12.47
Schrodinger (SDGR) United States $1.847B 0.00
Clover Health Investments (CLOV) United States $1.706B 0.00
Phreesia (PHR) United States $1.512B 0.00
Omnicell (OMCL) United States $1.460B 31.48
Azenta (AZTA) United States $1.232B 57.36
10x Genomics (TXG) United States $1.031B 0.00
Fulgent Genetics (FLGT) United States $0.634B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.537B 319.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.456B 0.00
TruBridge (TBRG) United States $0.392B 0.00
Claritev (CTEV) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.294B 0.00
Nyxoah SA (NYXH) Belgium $0.208B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.202B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.116B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.43
111 (YI) China $0.072B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Precipio (PRPO) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00